Êæºì±øÔºÊ¿¡¢Ö£º£Ñ§²©Ê¿·¢±íÃâÒßÑо¿Ð³ɹû
ÉúÎïͨ±¨µÀ À´×ÔÖйúũҵ¿ÆÑ§Ôº¡¢Î人´óѧµÄÑо¿ÈËԱ֤ʵ£¬¿ÚÌãÒß²¡¶¾½á¹¹µ°°×Vp3½µ½âJAK1ÒÖÖÆÁËIFN-¦Ã ÐźŴ«µ¼Í¨Â·¡£ÕâÒ»Ñо¿³É¹û·¢²¼ÔÚ2ÔÂ25Èյġ¶Cell cycle¡·ÔÓÖ¾ÉÏ¡£
Î人´óѧÉúÃü¿ÆÑ§Ñ§ÔºµÄÊæºì±ø£¨Hong-Bing Shu£©½ÌÊÚ£¬ºÍÖйúũҵ¿ÆÑ§ÔºµÄÖйúũҵ¿ÆÑ§ÔºÀ¼ÖÝÊÞÒ½Ñо¿Ëù¸±Ñо¿Ô±Ö£º£Ñ§£¨Hai-Xue Zheng£©ÊÇÕâÆªÂÛÎĵĹ²Í¬Í¨Ñ¶×÷Õß¡£Ö£º£Ñ§²©Ê¿Ö÷Òª´ÓÊ¿ÚÌãÒߵȲ¡¶¾±íÐͱäÒì¹æÂɼ°Æä·Ö×Ó»ù´¡¡¢¸ßЧÒßÃçÖê¹¹½¨¼°ÆäÒßÃçÑо¿£¬ÒÔ¼°¿ÚÌ㲡¶¾ËÞÖ÷ÊÈÐÔ±äÒìºÍÌìÈ»ÃâÒßÓ¦´ðµÈ·Ö×Ó»úÖÆÑо¿¡£Êæºì±øÖ÷Òª´ÓÊÂÃâÒßÏà¹ØµÄϸ°ûÐźŴ«µ¼Ñо¿£¬ÔÚ¿¹²¡¶¾ÌìÈ»ÃâÒß·´Ó¦µÈÁìÓòÈ¡µÃÁËһϵÁÐÓÐÖØÒª¹ú¼ÊÓ°ÏìµÄ³É¹û¡£2011Ä굱ѡΪÖйú¿ÆÑ§ÔºÔºÊ¿¡£
2014Äê1Ô£¬Êæºì±øÔºÊ¿Ö¤ÊµTRIM38ͨ¹ý½éµ¼ÈÜøÌåÒÀÀµÐÔµÄTAB2/3½µ½âÒÖÖÆÁËTNF¦ÁÓëIL-1¦ÂÓÕµ¼µÄNF-¦ÊB¼¤»î¡£Óɴ˽ÒʾÁËÒ»¸ö´Óǰδ֪µÄ¡¢Ï¸°ûͨ¹ýÒÖÖÆÑ×Ö¢·´Ó¦´Ó¶ø±ÜÃâTNF¦ÁºÍIL-1¦Â´¥·¢¹ý¶ÈÓꦵÄÃâÒß·´Ó¦µÄ·Ö×Ó»úÖÆ¡£Ñо¿ÂÛÎÄ·¢±íÔÚpNASÔÓÖ¾ÉÏ£¨Îä´óÊæºì±øÔºÊ¿pNAS·¢±íÃâÒßѧгɹû £©¡£
2014Ä꣬ËûÁìµ¼Î人´óѧ¡¢ÖпÆÔºÎ人²¡¶¾Ñо¿ËùµÄÑо¿ÈËԱ֤ʵ£¬ÄÚÖÊÍø£¨ER£©Ïà¹Øµ°°×ZDHHC1ÊÇDNA²¡¶¾´¥·¢µÄ¡¢MITA/STINGÒÀÀµÐÔÏÈÌìÃâÒßÐźŵÄÕýµ÷¿ØÒò×Ó¡£ÕâÒ»Ñо¿·¢ÏÖ·¢±íÔÚ¡¶Cell Host & Microbe ¡·ÔÓÖ¾ÉÏ£¨Îä´óÊæºì±øÔºÊ¿Cell×Ó¿¯·¢±í×îÐÂÃâÒ߳ɹû £©¡£
2015Äê11Ô£¬Êæºì±ø¿ÎÌâ×é֤ʵTRIM38ͨ¹ýÁ½¸öÑÐòÇÒ²»Í¬µÄ»úÖÆ¸ºÏòµ÷¿ØÁËTLR3/4½éµ¼µÄÌìÈ»ÃâÒߺÍÑ×Ö¢·´Ó¦¡£ÕâÒ»Ñо¿·¢ÏÖ·¢²¼ÔÚ11Ôµġ¶The Journal of Immunology¡·ÔÓÖ¾ÉÏ£¨Îä´óÊæºì±øÔºÊ¿JImmunol·¢±íÃâÒßгɹû £©¡£
±¾Ô£¬Î人´óѧ¡¢ºÓ±±´óѧºÍÖпÆÔºÎ人²¡¶¾Ñо¿ËùµÄÑо¿ÈËÔ±»¹Ö¤Êµ£¬pASD1ͨ¹ýÒÖÖÆÏ¸°ûºËÖÐTC45½éµ¼µÄSTAT3È¥Á×Ëữ´Ù½øÁËSTAT3µÄ»îÐÔºÍÖ×ÁöÉú³¤¡£ÕâÒ»Ñо¿½á¹û·¢²¼ÔÚ¡¶J Mol Cell Biol¡·ÔÓÖ¾ÉÏ£¨Î人´óÑ§Êæºì±øÔºÊ¿È¨ÍþÆÚ¿¯·¢±í°©Ö¢Ð³ɹû £©¡£
¿ÚÌãÒß²¡¶¾£¨FMDV£©ÊÇСRNA²¡¶¾¿Æ³ÉÔ±£¬Óëͬ¿ÆÆäËû³ÉÔ±ÓкܶàÏàËÆµÄÌØÕ÷£¬Ò²ÓÐÆä¶ÀÌØµÄÒ»Ð©ÌØµã¡£FMDVÊôÓÚ¿ÚÌãÒß²¡¶¾Êô¡£¸Ã¿Æ²¡¶¾ÊÇÒÑÖª×îСµÄ¶¯ÎïRNA²¡¶¾¡£FMDV¶ÔËÞÖ÷ÉÏÆ¤Ï¸°ûÓÐÇ¿ÁÒµÄÒ׸ÐÐÔ£¬¿Éµ¼ÖÂżÌãÊÞµÄÒ»ÖÖÁÒÐÔ²¡¡ª¡ª¿ÚÌãÒߣ¬²¢¶ÔÈËÒ²ÓиÐȾÐÔ£¬µ«²»ÖÂËÀ¡£ÎªÁËÔÚÌåÄÚÓÐЧ¸´ÖÆ£¬FMDV½ø»¯³öÁËһЩ·½·¨À´¶ã±ÜËÞÖ÷¿¹²¡¶¾·ÀÓù»úÖÆ£¬°üÀ¨¸ÉÈÅËØ(IFNs)ÓÕµ¼µÄ·ÀÓù¡£ÒÔÍùµÄÑо¿Ò»Ö±½«½¹µã·ÅÔÚFMDV LproºÍ3Cpro¶ÔIÐÍIFNsµÄÓ°ÏìÉÏ¡£
StemSureÎÞѪÇå¸Éϸ°û¶³´æÒº Ãâ·ÑÊÔÓúÃÀñµÈÄãÄã¡
ÔÚÕâÏîÐÂÑо¿ÖУ¬Ñо¿ÈËԱ֤ʵFMDV Vp3ÒÖÖÆÁËIIÐÍIFNÐźÅͨ·¡£FMDV Vp3¹ý±í´ïÒÖÖÆÁËIFN-¦Ã´¥·¢µÄSTAT1 Tyr701λµãÁ×Ëữ¼°ËæºóÏÂÓλùÒòµÄ±í´ï¡£»úÖÆÑо¿Ö¤Êµ£¬FMDV Vp3ÓëJAK1/2»¥×÷£¬ÒÖÖÆÁËSTAT1µÄÀÒ°±ËáÁ×Ëữ¡¢¶þ¾Û»¯ºÍºËÀÛ»ý¡£FMDV Vp3»¹ÆÆ»µÁËJAK1¸´ºÏÎïµÄ×é×°£¬²¢Í¨¹ýÒ»ÌõÈÜøÌåÐźÅͨ·½µ½âÁËJAK1¡£
ÕâЩÑо¿½á¹û½Òʾ³öÁËFMDV Vp3¶Ô¿¹IIÐÍIFNÐźÅͨ·µÄÒ»ÖÖлúÖÆ¡£
£¨ÉúÎïͨ£ººÎæÍ£©
ÉúÎïÍ¨ÍÆ¼öÔÎÄÕªÒª£º
Foot-and-mouth disease virus structural protein Vp3 degrades Janus kinase 1 to inhibit IFN-¦Ã signal transduction pathways.
Foot-and-mouth disease is a highly contagious viral disease of cloven-hoofed animals that is caused by foot-and-mouth disease virus (FMDV). To replicate efficiently in vivo, FMDV has evolved methods to circumvent host antiviral defense mechanisms, including those induced by interferons (IFNs). previous research has focused on the effect of FMDV Lpro and 3Cpro on type I IFNs. In this study, FMDV Vp3 was found to inhibit type II IFN signaling pathways. The overexpression of FMDV Vp3 inhibited the IFN-¦Ã-triggered phosphorylation of STAT1 at Tyr701 and the subsequent expression of downstream genes. Mechanistically, FMDV Vp3 interacted with JAK1/2 and inhibited the tyrosine phosphorylation, dimerization and nuclear accumulation of STAT1. FMDV Vp3 also disrupted the assembly of the JAK1 complex and degraded JAK1 but not JAK2 via a lysosomal pathway. Taken together, the results reveal a novel mechanism used by which FMDV Vp3 counteracts the type II IFN signaling pathways.
×÷Õß¼ò½é£º
Êæºì±ø
Öйú¿ÆÑ§ÔºÔºÊ¿£¬½ÌÊÚ£¬²©Ê¿Éúµ¼Ê¦¡£ÏÖÈÎÎ人´óѧÉúÃü¿ÆÑ§Ñ§ÔºÔº³¤¡¢Öйúϸ°ûÉúÎïѧѧ»á¸±Àíʳ¤¡£1987Äê±ÏÒµÓÚÀ¼ÖÝ´óѧÉúÎïѧϵ£¬1990Äê»ñÖйúҽѧ¿ÆÑ§Ôº»ù´¡Ò½Ñ§Ñо¿Ëù˶ʿѧ룬1995ÄêÓÚÃÀ¹úEmory´óѧ»ñ²©Ê¿Ñ§Î»¡£2011Ä굱ѡÖйú¿ÆÑ§ÔºÔºÊ¿¡£
ϸ°ûÉúÎïѧ¡¢ÃâÒßѧר¼Ò£¬Ö÷Òª´ÓÊÂÃâÒßÏà¹ØµÄϸ°ûÐźÅתµ¼Ñо¿£¬ÔÚ¿¹²¡¶¾ÌìÈ»ÃâÒß·´Ó¦µÈÁìÓòÈ¡µÃÁËһϵÁÐÓÐÖØÒª¹ú¼ÊÓ°ÏìµÄ³É¹û¡£·¢ÏÖÁ˶à¸öÔÚ²¡¶¾¸ÐȾÓÕµ¼Ï¸°û±í´ïIÐ͸ÉÈÅËØµÄ¹ý³ÌÖз¢»Ó¹Ø¼ü×÷ÓõÄÐźŵ°°×£¬ÎªÁ˽âϸ°û¿¹²¡¶¾·´Ó¦µÄ·Ö×Ó»úÖÆ×ö³öÁËÖØÒª¹±Ï×£»·¢ÏÖÁ˶à¸ö¸ºµ÷¿ØIÐ͸ÉÈÅËØ¹ýÁ¿±í´ïµÄµ°°×ºÍ×÷ÓûúÖÆ£¬ÕâÖÖ¾«Ï¸µ÷¿Ø»úÖÆ±ÜÃâ»úÌå²úÉú¹ý¼¤µÄÃâÒß·´Ó¦£»·¢ÏÖÁËеÄÖ×Áö»µËÀÒò×Ó¼Ò×å³ÉÔ±£¬²ûÊöÁËÖ×Áö»µËÀÒò×Ó¼Ò×åµÄ¶à¸ö³ÉÔ±ÐźÅתµ¼µÄÔçÆÚ·Ö×Óʼþ£¬ÎªÁ˽âÏà¹ØÃâÒß¼²²¡µÄ·Ö×Ó»úÖÆ×ö³öÁ˹±Ïס£
Ö£º£Ñ§
ÄУ¬1979Äê4ÔÂÉú£¬²©Ê¿£¬¸±Ñо¿Ô±£¬Ë¶µ¼¡£2002Äê»ñºÓÄÏũҵ´óѧÊÞҽרҵũѧʿѧλ£»2007Äê»ñÖйúũҵ¿ÆÑ§ÔºÅ©Ñ§²©Ê¿Ñ§Î»¡£2007Äê7Ô¡«2008Äê4Ô£¬¹ãÖÝũҵ¿ÆÑ§ÔºÊÞÒ½Ñо¿Ëù¹¤×÷£»2008Äê5Ô¡«2009Äê3Ô£¬ÔÚÊÀ½ç¿ÚÌãÒ߲ο¼ÊµÑ鹤×÷ѧϰ¡£2009Äê5Ôµ÷ÈëÖйúũҵ¿ÆÑ§ÔºÀ¼ÖÝÊÞÒ½Ñо¿Ëù¹¤×÷£¬Èβ¡¶¾»ùÒò¹¤³Ì×鸺ÔðÈË£¬Ö÷Òª´ÓÊ¿ÚÌãÒߵȲ¡¶¾±íÐͱäÒì¹æÂɼ°Æä·Ö×Ó»ù´¡¡¢¸ßЧÒßÃçÖê¹¹½¨¼°ÆäÒßÃçÑо¿£¬ÒÔ¼°¿ÚÌ㲡¶¾ËÞÖ÷ÊÈÐÔ±äÒìºÍÌìÈ»ÃâÒßÓ¦´ðµÈ·Ö×Ó»úÖÆÑо¿¡£ÏȺó²Î¼ÓºÍÖ÷³Ö¡°863¡±¡¢¡°973¡±¡¢¡°¹ú¼ÒÖ§³Å¡±ÒÔ¼°Ê¡²¿¼¶ÏîÄ¿¶àÏî¡£